血浆维生素D代谢物与2型糖尿病发病的关联:EPIC-InterAct病例-队列研究
该研究基于EPIC-InterAct病例-队列研究,纳入9671例新发2型糖尿病病例和13562名亚队列成员,采用液相色谱-质谱法检测血浆维生素D代谢物。多变量Prentice加权Cox回归显示,总25(OH)D和非差向异构25(OH)D3与2型糖尿病发病呈负相关,差向异构25(OH)D3呈正相关,而25(OH)D2无显著关联。
要点
- 总25(OH)D和非差向异构25(OH)D3每增加1 SD,2型糖尿病风险降低(HR=0.81)。
- 差向异构25(OH)D3每增加1 SD,2型糖尿病风险升高(HR=1.16)。
- 25(OH)D2与2型糖尿病发病无统计学显著关联。
核心结论
- 血浆非差向异构25(OH)D3与2型糖尿病发病呈负相关,与作为总25(OH)D主要贡献代谢物一致。
- 差向异构25(OH)D3与2型糖尿病发病呈正相关,为评估维生素D差向异构化的生物学相关性提供新信息。
研究设计与样本
- EPIC-InterAct病例-队列研究,纳入9671例新发2型糖尿病病例和13562名亚队列成员。
- 血浆维生素D代谢物采用液相色谱-质谱法量化。
- 采用多变量Prentice加权Cox回归估计风险比,按国家分别分析后用随机效应荟萃分析合并。
主要发现
- 总25(OH)D、非差向异构25(OH)D3、差向异构25(OH)D3和25(OH)D2的平均浓度(SD)分别为41.1(17.2)、40.7(17.3)、2.13(1.31)和8.16(6.52)nmol/L。
- 总25(OH)D和非差向异构25(OH)D3每1 SD的多变量校正HR均为0.81(95% CI,0.77,0.86)。
- 差向异构25(OH)D3每1 SD的HR为1.16(95% CI,1.09,1.25)。
- 25(OH)D2每1 SD的HR为0.94(95% CI,0.76,1.18),无统计学显著关联。
临床怎么用
- 解读血浆总25(OH)D与2型糖尿病风险时,可考虑其代谢物组成尤其是非差向异构25(OH)D3的贡献。
- 差向异构25(OH)D3与2型糖尿病风险的关联提示未来可评估维生素D差向异构化在糖尿病病因学中的生物学意义。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Existing evidence for the prospective association of vitamin D status with type 2 diabetes (T2D) is focused almost exclusively on circulating total 25-hydroxyvitamin D [25(OH)D] without distinction between its subtypes: nonepimeric and epimeric 25(OH)D3 stereoisomers, and 25(OH)D2, the minor component of 25(OH)D. We aimed to investigate the prospective associations of circulating levels of the sum and each of these three metabolites with incident T2D. METHODS: This analysis in the European Prospective Investigation into Cancer and Nutrition (EPIC)-InterAct case-cohort study for T2D included 9671 incident T2D cases and 13,562 subcohort members. Plasma vitamin D metabolites were quantified by liquid chromatography-mass spectrometry. We used a multivariable Prentice-weighted Cox regression to estimate hazard ratios (HRs) of T2D for each metabolite. Analyses were performed separately within country, and estimates were combined across countries using random-effects meta-analysis. RESULTS: The mean concentrations (SD) of total 25(OH)D, nonepimeric 25(OH)D3, epimeric 25(OH)D3, and 25(OH)D2 were 41.1 (17.2), 40.7 (17.3), 2.13 (1.31), and 8.16 (6.52) nmol/L, respectively. Plasma total 25(OH)D and nonepimeric 25(OH)D3 were inversely associated with incident T2D [multivariable-adjusted HR per 1 SD = 0.81 (95% CI, 0.77, 0.86) for both variables], whereas epimeric 25(OH)D3 was positively associated [per 1 SD HR = 1.16 (1.09, 1.25)]. There was no statistically significant association with T2D for 25(OH)D2 [per 1 SD HR = 0.94 (0.76, 1.18)]. CONCLUSIONS: Plasma nonepimeric 25(OH)D3 was inversely associated with incident T2D, consistent with it being the major metabolite contributing to total 25(OH)D. The positive association of the epimeric form of 25(OH)D3 with incident T2D provides novel information to assess the biological relevance of vitamin D epimerization and vitamin D subtypes in diabetes etiology.
引用
- Zheng JS, Imamura F, Sharp SJ, et al. Association of Plasma Vitamin D Metabolites With Incident Type 2 Diabetes: EPIC-InterAct Case-Cohort Study. J Clin Endocrinol Metab. 2019. PMID: 30418614. doi:10.1210/jc.2018-01522
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。